We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into UiPath (PATH) Q1: Wall Street Projections for Key Metrics
Read MoreHide Full Article
The upcoming report from UiPath (PATH - Free Report) is expected to reveal quarterly earnings of $0.10 per share, indicating a decline of 23.1% compared to the year-ago period. Analysts forecast revenues of $332.33 million, representing a decrease of 0.8% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain UiPath metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Revenue- Licenses' should come in at $115.46 million. The estimate suggests a change of -17.6% year over year.
The consensus estimate for 'ARR' stands at $1.69 billion. The estimate compares to the year-ago value of $1.51 billion.
Analysts forecast 'Net New ARR' to reach $22.09 million. Compared to the present estimate, the company reported $44 million in the same quarter last year.
Over the past month, shares of UiPath have returned +9% versus the Zacks S&P 500 composite's +10.7% change. Currently, PATH carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into UiPath (PATH) Q1: Wall Street Projections for Key Metrics
The upcoming report from UiPath (PATH - Free Report) is expected to reveal quarterly earnings of $0.10 per share, indicating a decline of 23.1% compared to the year-ago period. Analysts forecast revenues of $332.33 million, representing a decrease of 0.8% year over year.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain UiPath metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Revenue- Licenses' should come in at $115.46 million. The estimate suggests a change of -17.6% year over year.
The consensus estimate for 'ARR' stands at $1.69 billion. The estimate compares to the year-ago value of $1.51 billion.
Analysts forecast 'Net New ARR' to reach $22.09 million. Compared to the present estimate, the company reported $44 million in the same quarter last year.
View all Key Company Metrics for UiPath here>>>
Over the past month, shares of UiPath have returned +9% versus the Zacks S&P 500 composite's +10.7% change. Currently, PATH carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>